Legal

Veozah Liver Injury Lawsuit: Who May Have a Claim in 2026

Daylongs ·
#Veozah #fezolinetant #liver injury #boxed warning #Astellas #drug injury lawsuit #failure to warn #menopause hot flashes #product liability

What is the Veozah liver injury lawsuit about?

A Veozah liver injury lawsuit is a product liability claim by a patient who says the hot-flash drug fezolinetant damaged their liver and that its maker, Astellas, did not warn strongly enough. Whether any such case has reached a ruling is unconfirmed.

Here is the honest state of play as of November 19, 2026. The medical facts are well documented by the FDA. The litigation facts are thin. When I searched, I found law-firm marketing pages saying that people with liver damage have filed or are preparing claims against Astellas. I did not find a court docket, a consolidated federal proceeding, a judge’s order or a settlement. So this guide treats the legal side as unconfirmed and spends its effort on what you can verify and control: the safety history, the records, and the deadlines.

Veozah is a non-hormonal pill approved by the FDA in 2023 for moderate to severe hot flashes (vasomotor symptoms) caused by menopause. It works on a brain pathway rather than replacing estrogen, which is why women who cannot or do not want hormone therapy were interested in it.

This article is general information, not legal advice. I am not a lawyer, and the facts below were checked through search summaries because the FDA site itself did not open for me in this session.

What did the FDA say about Veozah and liver injury?

The FDA added a boxed warning for rare but serious liver injury on December 16, 2024, after a September 2024 safety communication. The FDA announcement is the primary source.

The sequence matters for a legal reader, so here it is in a table.

DateEventWhat it means
2023FDA approves VeozahLabel already carried liver-related precautions
Sept 2024FDA safety communicationTriggered by a case report of liver injury after about 40 days of use
Dec 16, 2024Boxed warning addedHighlights an existing risk, with liver testing emphasized
Early 2025UK regulator asked for updated warnings (per a legal-news summary)Check the regulator’s own page

Two points are easy to miss. First, a boxed warning is the FDA’s most prominent label warning, but it does not mean the drug was pulled. Veozah stayed on the market. Second, the label said “rare.” In the clinical-trial data summarized in trade coverage, elevated liver enzymes appeared in about 2.3% of fezolinetant users versus about 0.9% on placebo. Enzyme elevations are not the same as clinical liver failure, and that gap is where many disputes over causation live.

I could not open the prescribing information itself, so I am not quoting its exact stop rules or contraindications. Read the current label on DailyMed before you rely on any summary, mine included.

What do Veozah lawsuits allege against Astellas?

The typical allegation is failure to warn: that the company knew or should have known about liver risk and did not give doctors and patients clear enough information or monitoring instructions early enough. Those allegations come from law-firm pages, not from a court opinion I read.

Product liability claims over prescription drugs generally rest on a few recognized theories:

  • Failure to warn. The label or marketing understated a risk, or the warning came too late for the person who was hurt.
  • Design defect. The drug is unreasonably dangerous compared with alternatives. These are harder against an FDA-approved pill.
  • Negligence and misrepresentation. The company’s testing or statements fell short of what a careful manufacturer would do.

The defense side of any such case tends to look the same: the risk was disclosed, the FDA reviewed the label, the injury has another explanation (alcohol, other medicines, fatty liver, a viral infection), and the patient’s doctor was the one who decided to prescribe. Each of those is a real argument, which is why records matter so much. For the general mechanics of how drug cases are built and paid, see our defective drug lawsuit and settlement guide.

Is there a Veozah MDL or settlement?

I could not confirm either. A multidistrict litigation, or MDL, is a federal procedure that gathers similar lawsuits before one judge for pretrial work. Nothing I found showed the Judicial Panel on Multidistrict Litigation creating one for Veozah.

Do not take my word for that, because dockets change weekly. The Panel publishes its pending MDL information and you can search the case names on PACER. If a lawyer tells you an MDL exists, ask for the MDL number and the judge’s name, then check them yourself.

Be especially careful with three things you will see online:

  1. Payout ranges. Without a sourced settlement or verdict, a dollar figure for Veozah is invented.
  2. “Claim deadline” countdowns. Without a settlement program, there is no claims deadline, only your own statute of limitations.
  3. “You may be entitled to compensation” banners. These are lead-generation ads. Some are run by law firms, some by marketers who sell your phone number.

For comparison, other recent drug-injury matters do have documented structures, such as the federal proceedings we cover for Dupixent and lymphoma and Oxbryta. Veozah is not at that confirmed stage as far as I could verify.

Who might qualify for a Veozah liver injury claim?

You may have a claim if you took Veozah, later developed documented liver injury, and can show through records that the drug, not something else, plausibly caused it. A lawyer makes that call; no website can.

Lawyers screening these cases usually look at the following.

QuestionWhy it matters
Did you actually take Veozah (fezolinetant)?Pharmacy fill history proves exposure
What liver finding followed?Lab values and a diagnosis, not just “felt unwell”
How soon after starting?Timing supports or weakens causation
Were baseline and follow-up liver tests done?Missed monitoring can matter to who is responsible
Other possible causes?Alcohol, acetaminophen, other drugs, hepatitis, fatty liver
OutcomeHospitalization, transplant evaluation, lasting damage, lost work
When did you learn of a possible link?Starts the clock in many states

If your liver enzymes ticked up slightly and came back to normal after you stopped, many lawyers will tell you the case is small or not viable. That is not a judgment on whether you were harmed; it reflects how much compensable damage there is. Serious injury, such as jaundice, hospitalization or lasting impairment, is where a case is more likely to be taken on.

What should I do if I think Veozah hurt my liver?

Get medical care first, then preserve evidence. Call your prescriber if you have yellow skin or eyes, dark urine, pale stools, itching, upper right abdominal pain, severe fatigue, nausea or vomiting. Do not self-diagnose and do not quit or restart medication without clinical advice.

After you are medically safe, work through this list.

  1. Report it. You or your clinician can file with the FDA through MedWatch. A report is not a lawsuit, but it creates a government record.
  2. Request your records. Ask for the full chart, not a summary: every liver panel, imaging, clinic and ER notes.
  3. Get pharmacy history. The printout should show fill dates and dose.
  4. Photograph what you have. The bottle, the patient leaflet, and any paperwork from the day you started.
  5. Write a timeline. Start date, first symptom, first abnormal lab, diagnosis, treatment. Do it now while your memory is fresh.
  6. List everything else you took. Supplements, pain relievers, alcohol use, herbal products. A good lawyer will ask; an honest list protects your credibility.
  7. Keep bills and pay stubs. Medical expenses and missed work are part of damages.
  8. Stay quiet publicly. Posts about your illness can be used by the other side.

A composite example: where a claim goes wrong

Consider a composite, not a real person. A woman in her fifties starts Veozah, feels tired in week five, and assumes it is menopause itself. She gets a liver panel at month three, as the monitoring schedule describes, and her enzymes are high. Her doctor stops the drug. She recovers over a few months, then hears about lawsuits and calls a firm two and a half years later, after she has thrown out the bottle and lost the patient paperwork.

Three things hurt her. The recovery was complete, so damages are modest. The deadline in her state is two years, so a court may say she waited too long. And she cannot easily show the exact dose and dates. Any one of those can end a case.

The lesson is not that she did anything unreasonable. It is that deadlines and records decide drug cases as much as medicine does.

What is the statute of limitations on a drug injury claim?

It depends on your state, and many states give roughly two to three years from the injury or from when you reasonably should have discovered the connection to the drug. Some are shorter, some longer, and wrongful-death rules can differ.

Do not rely on a general number. The discovery rule, which can delay the start of the clock, is applied unevenly, and courts have refused to extend it where a boxed warning was already public. A boxed warning in December 2024 is a fact a defense lawyer may point to when arguing you should have known sooner. I am not saying that argument would win. I am saying it is a reason not to wait.

A short consult costs little. Many personal injury firms handling drug cases take them on contingency, meaning no fee unless there is a recovery, but get the fee percentage and cost terms in writing. For a broader look at deadlines across injury cases, see wrongful death lawsuit rules, which explains how state limits differ, and our guide to suing over a defective product.

How do Veozah claims compare with other drug-warning cases?

They share a pattern: a drug is approved, a safety signal appears, the label is strengthened, and patients who were hurt before the change argue the warning should have come sooner.

DrugIssueRegulatory stepWhere to read more
VeozahLiver injuryBoxed warning, Dec 2024This guide
SingulairNeuropsychiatric eventsBoxed warning, 2020Singulair lawsuit guide
ElmironPigmentary maculopathyLabel updatesElmiron MDL guide
ZantacAlleged NDMA cancer linkMarket withdrawal, 2020Zantac MDL guide

The comparison is useful because it shows how long these things take. A warning in one year, lawsuits in the next, a consolidated proceeding after that, and resolutions years later. A strengthened warning does not predict a payout. It predicts that someone will test the question in court, and the outcome is open.

What if my doctor prescribed it and monitored me properly?

Then the question shifts. If you were tested on schedule and the drug was stopped promptly, a claim against the manufacturer may be weaker, and the lawyer will want to know whether the harm came despite good care.

That does not close the door. Warning-adequacy claims focus on what the label said when you were prescribed the drug, not only on what happened afterward. If your injury occurred before the December 2024 boxed warning, the earlier label’s wording is likely central. If it occurred after, the company will argue the warning was already prominent.

Separately, if the testing the label called for was skipped, that could point to a medical malpractice issue instead of, or alongside, a product claim. Those are different cases with different deadlines and expert requirements. Our medical malpractice settlement guide covers how that route works.

How do I choose a lawyer for a Veozah case?

Pick someone who handles pharmaceutical injury, not a general advertiser, and ask direct questions. Ask how many drug cases they have actually litigated, whether they will work the case themselves or refer it out, what the fee and cost terms are, and what they know about the current docket status.

A good answer to “is there an MDL?” is specific: a number, a judge, a date. A bad answer is a vague “cases are moving forward.” If someone promises a payout, walk away. No honest lawyer can promise one on a drug where I could find no confirmed resolution.

Also watch for intake calls that ask for your Social Security number before you have a signed agreement. Share medical history through the firm’s secure portal, and read what you sign.

What I could and could not verify

I confirmed through multiple search summaries that the FDA added the boxed warning on December 16, 2024, following a September 2024 communication. I confirmed that plaintiff-side firms advertise Veozah liver injury cases. I could not open the FDA page, the prescribing information, any court docket or the JPML list in this session, so the monitoring schedule is described as press coverage reports it and should be checked against the label. I found no confirmed MDL, ruling, trial or settlement. If that changes, this page should be updated, not trusted blindly.

This article is for general information and is not legal or medical advice. Laws, deadlines and litigation status change; talk to a licensed attorney in your state and to your prescriber about your own situation. Last reviewed November 19, 2026.

Is there a Veozah liver injury lawsuit?

Plaintiff law firms say individual patients have sued or are preparing to sue Astellas over liver injury. I could not confirm a court docket, a consolidated federal proceeding, a ruling or a settlement. Treat the litigation status as unconfirmed and check court records or ask a lawyer.

When did the FDA add a boxed warning to Veozah?

The FDA added a boxed warning for rare but serious liver injury on December 16, 2024. It followed a September 2024 safety communication that was triggered by a reported case of liver injury in a patient who had taken the drug for roughly 40 days.

What liver tests does Veozah require?

Press coverage of the label describes a baseline liver blood test before starting and repeat testing at about two months and then at months 3, 6 and 9. Some summaries differ on the exact early schedule, so confirm against the current prescribing information.

What are the signs of liver injury on Veozah?

Warning signs commonly listed include yellowing of the skin or eyes, dark urine, pale stools, itching, right-sided upper abdominal pain, unusual tiredness, nausea or vomiting. Call your prescriber promptly if these appear, and do not wait for the next scheduled lab.

Who might qualify for a Veozah claim?

Generally someone who took Veozah, developed documented liver injury afterward, and has pharmacy and medical records connecting the two. Whether you qualify is a lawyer's judgment based on your records, other causes of liver trouble and your state's deadline.

What is the statute of limitations for a drug injury claim?

It varies by state, and many states allow two to three years, sometimes counted from when you knew or should have known the injury was connected to the drug. Some have shorter or longer rules, so get state-specific advice quickly.

Should I stop taking Veozah to protect a claim?

Do not stop or change any prescription on your own because of a lawsuit. Talk to the prescriber about symptoms and lab results. The medical decision and the legal question are separate, and your health comes first.

What records should I keep?

Prescriptions and pharmacy fill history, every liver panel with dates, doctor and ER notes, imaging, a list of other medicines and supplements, a symptom diary, and bills. Photograph the bottle and save the patient leaflet you were given.

Is a Veozah lawsuit a class action?

Not as far as I could confirm. Drug injury cases are usually individual claims, and even when courts coordinate many of them, each person's injuries and damages are evaluated separately.

How much is a Veozah lawsuit worth?

No sourced settlement or verdict amount exists that I could find, so any figure quoted online is a guess. Value would depend on severity, hospitalization, lasting damage, lost income and the strength of the causation evidence.

공유하기

관련 글